株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

幹細胞研究の世界市場

Stem Cells

発行 Global Industry Analysts, Inc. 商品コード 243086
出版日 ページ情報 英文 229 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
幹細胞研究の世界市場 Stem Cells
出版日: 2017年05月01日 ページ情報: 英文 229 Pages
概要

当レポートでは、幹細胞研究の世界市場を分析し、米国/欧州/その他の地域についての包括的な地域別分析を提供し、2008-2017年間の年間業績を推定/予測するとともに、主要/ニッチプレーヤ87社の企業プロファイルを盛り込み、概略下記の構成でお届けいたします。

第1章 イントロダクション、方法論、製品定義

第2章 エグゼクティブサマリ

第3章 市場概要

  • 概要
  • これまでの主要な成果
  • 幹細胞研究における大きな歴史的出来事
  • 新たな成長分野
  • 整形外科用製品:有望な成長部門
  • 臍帯血幹細胞の実用的機能
  • 課題
  • 幹細胞研究と倫理的角度

第4章 市場の動態とトレンド

  • 北米が世界の幹細胞市場を支配
  • 医療分野を再形成する幹細胞の躍進
  • 世界初の体性幹細胞ベースの治療を公開する韓国
  • 新技術への甚大な関心
  • 倫理的問題と発生期状態:幹細胞の主要市場阻害要因
  • 幹細胞治療における医療ツアーの上昇
  • 幹細胞治療の医療ツアーを防止せずにいる政府規制
  • 幹細胞特許において欧州に大きく差をつける米国と日本

第5章 幹細胞市場の動態:タイプ別

  • 成人体幹細胞が握る多大な可能性
  • 成体幹細胞と胚性幹細胞:比較
  • ロー・リスクの投資
  • 成体幹細胞の方が多くの研究用投資を集める
  • 汎用性の低さ:成体幹細胞の主な制限要因
  • 造血幹細胞:持続的な成功に沸く
  • 阻害要因
  • 間充織幹細胞:有望な治療的オプション
  • 隔離性の難しさと理解度の低さが成長を阻害
  • 人工多能性幹細胞:ESCの代替
  • iPS発見の概要
  • 医薬品開発:iPSの主要アプリケーション
  • 再生医療
  • iPS細胞バンクの構築
  • 難病/先天性疾患の治療
  • 臓器治療
  • 医療分野を一変させる胚性幹細胞
  • 安全性と有効性のデータ不足が引き続き問題

第6章 アプリケーション別幹細胞研究

  • 疾病管理における幹細胞
  • 再生医療における幹細胞治療
  • 幹細胞治療:神経障害に対する有望な治療
  • 大規模な研究に要求される心臓血管系疾患における早期的成果の立証
  • 癌の幹細胞治療
  • 個人医療に足を踏み入れる幹細胞
  • 高齢化人口が促進する整形外科向け幹細胞市場
  • その他の疾患
  • ドラッグデリバリーにおける幹細胞
  • 医薬品開発用ツール

第7章 規制環境

  • 幹細胞研究を支配する法律:分断された世界
  • 主要国における幹細胞研究の法律と規制

第8章 製品概要

  • 幹細胞研究
  • 幹細胞:解説
  • 幹細胞のタイプ
  • 胚性幹細胞
  • 成体幹細胞
  • その他の主要細胞タイプ
  • 幹細胞:特性
  • 自然に再生する能力
  • 可能性
  • 多様な潜在力の定義
  • 幹細胞の識別
  • 幹細胞:アプリケーション
  • 幹細胞の歴史
  • 幹細胞:サービスと製品
  • 幹細胞製品/サービスの重大性

第9章 研究の飛躍的発見

第10章 製品紹介/革新

第11章 最近の業界活動

第12章 戦略的企業発展:歴史的展望材料

第13章 世界の主要プレーヤへの焦点

第14章 世界市場展望

  • 米国
  • 欧州
  • その他の地域

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6142

This report analyzes the worldwide markets for Stem Cell Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 66 companies including many key and niche players such as -

Athersys, Inc.
Apceth GmbH & Co.KG
AVIVA BioSciences Corporation
BioE, Inc.
Bone Therapeutics SA

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Types of Stem Cells
      • Embryonic Stem Cells
      • Adult Stem Cells

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries
  • Select Approved Stem Cell Products
  • Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
  • Trends Related to Stem Cell Clinical Trials
    • Table 1: Clinical Tests by Type: Allogenic Vs. Autologous (In %) (includes corresponding Graph/Chart)
    • Table 2: Stem Cells Clinical Trials by Country: 2008-2014 (includes corresponding Graph/Chart)
  • Select Stem Cell Pipeline Analysis
  • Current & Future Analysis
  • Stem Cell Research Funding Policies across the World
  • Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research
  • Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications
  • Dental Mesenchymal Stem Cells - Emergence of a Niche Market
  • For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research
  • Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern

2. STEM CELL RESEARCH INNOVATIONS

  • Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells
  • Embryonic Stem Cell Gene Nanog Found to Reverse Aging
  • Canadian and Dutch Scientists Finds the "Genetic Switch" to Increase Stem Cell Volume from Cord Blood
  • The Boston Program Pioneers Cell-based Personalized Diabetes Treatment
  • iPSCs Provide Valuable Source for Retinal Transplants and Other Applications
  • Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders
  • Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients?
  • Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted
  • Adverse Reactions of Stem Cell-Face Lift Therapy
  • Stem Cell-Breast Enhancement
  • Other Innovations Using Stem Cells
  • New Stem Cell Software & Products

3. PRODUCT OVERVIEW

  • Stem Cell Research
  • Stem Cells - Description
  • Types of Stem Cells
  • Embryonic Stem Cells
    • mES and hES
    • R-NSCs
  • Adult Stem Cells
  • Hematopoietic Stem Cells
  • Mesenchymal Stem Cells
  • Umbilical Cord Stem Cells
  • Neuronal Stem Cells
  • Dental Stem Cells
  • Pluripotent Adult Stem Cells
  • Other Key Cell Types
  • The Stem Cell Line - Cell Division
  • Stem Cells - Properties
  • Ability to Renew on its Own
  • Potency
  • Definitions of Various Potencies
  • Identification of Stem Cells
  • Stem Cells - Applications
  • History of Stem Cells
  • Stem Cells - Services and Products
  • Significance of Stem Cell Products/Services

4. PRODUCT LAUNCHES

  • Minerva Biotechnologies Launches AlphaSTEM(tm), a Naive Stem Cell Culture System
  • Takara Bio Launches Human iPSC-Derived Beta Cells for Drug Screening and Diabetes Research
  • RenovaCare Develops New Stem Cell Device for Burn Injuries
  • Mesoblast Launches the World's First Off-The-Shelf Stem Cell Treatment
  • Mesoblast Licensee launches first stem cell product in Japan
  • Stempeutics Research Receives Approval for India's First Stem Cell Based Drug

5. CLINICAL TRIALS

  • Nature Cell Commences Phase I and II Clinical Trials of 'ASTROSTEM' in the US for Treating Alzheimer
  • Tisch MS Research Center Commences Phase II Stem Cell Clinical Trial for MS
  • Canadian Clinical Trial to Test Neural Stem Cells in Patients with Spinal Cord Injuries
  • Neuralstem's ALS Stem Cell Therapy Exhibits Safety and Efficacy in Early Clinical Trials
  • The University of Michigan Commences Large Scale Clinical Trials for ALS Therapy
  • Bionomics Receives FDA Approval for Phase I Clinical Trial in Cancer Patients
  • AHSCT Shows Reduced Brain Lesions in Phase 2 Clinical Trial
  • Neuralstem's Neural Stem Cell Treatment Meets Primary Safety Endpoints in Phase 2 Trials

6. RECENT INDUSTRY ACTIVITY

  • GE Health Acquires Biosafe
  • Human Longevity Acquires Lifebank
  • AbbVie to Acquire Stemcentrx and Its Lead Asset Rova-T
  • Thorn Medical Acquires Okyanos Holding Company
  • Bio-Techne Corporation Acquires Zephyrus Biosciences
  • Astellas Pharma to Complete Acquisition of Ocata Therapeutics
  • Bayer Launches Stem Cell Therapy Company BlueRock Therapeutics
  • apceth Signs License Option Agreement with Cynata Therapeutics Ltd
  • StemBioSys Announces European Distribution Agreement with Cellaviva AB of Sweden
  • Fujifilm Holdings Acquires Cellular Dynamics International
  • American CryoStem Corporation Acquires Biolife Cell Bank
  • NeoStem Announces Plans to Change Name to Caladrius Biosciences Reflecting Transformation into Immunotherapy Company
  • ESI BIO Announces Alliance Agreement with Pivotal Scientific Ltd for Distribution of Stem Cell Products
  • TiGenix and Lonza Signs Agreement for the Manufacture of Stem Cell-based Treatment
  • AlloSource Receives Patent for AlloStem(r) Cellular Bone Allograft

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Athersys, Inc. (USA)
  • Apceth GmbH & Co.KG (Germany)
  • AVIVA BioSciences Corporation (USA)
  • BioE, Inc. (USA)
  • Bone Therapeutics SA (Belgium)
  • Cesca Therapeutics, Inc. (USA)
  • Cryo-Cell International, Inc. (USA)
  • Cytori Therapeutics, Inc. (USA)
  • ESI BIO, a Division of BioTime Inc. (USA)
  • Gamida Cell Ltd. (Israel)
  • Holostem Terapie Avanzate (Italy)
  • International Stem Cell Corporation (USA)
  • Kangstem Biotech., Ltd. (Korea)
  • Lonza Group Ltd (Switzerland)
  • Mesoblast Ltd. (Australia)
  • Neuralstem, Inc. (USA)
  • Nuvasive, Inc. (USA)
  • Osiris Therapeutics, Inc. (USA)
  • OncoMed Pharmaceuticals, Inc (USA)
  • PROMETHERA Biosciences S.A.N.V (Belgium)
  • Reliance Life Sciences (India)
  • ReNeuron Group Plc. (UK)
  • STEMCELL Technologies, Inc. (Canada)
  • Stemedica Cell Technologies, Inc (USA)
  • Stempeutics Research Pvt. Ltd. (India)
  • Takara Bio USA Inc (USA)
  • TiGenix NV (Belgium)
  • U.S Stem Cell, Inc. (USA)
  • ViaCord, LLC (USA)

8. GLOBAL MARKET PERSPECTIVE

    • Table 3: World Recent Past, Current and Future Analysis for Stem Cell Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 4: World 8-Year Perspective for Stem Cell Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2017 and 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Hemacord - The Only FDA-Approved Cord Blood- Derived Hematopoietic Progenitor Cells
    • FDA to Implement Strict Regulations on Unapproved Stem Cell Treatment
    • Consumer Watchdog against Embryonic- Stem Cell Patents
    • Clinical Trials
    • Strategic Corporate Developments
    • Product Launches
    • Select Key Players
  • B. Market Analytics
    • Table 5: The US Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Stem Cell Initiatives
    • Clinical Trials
    • Select Key Player
  • B. Market Analytics
    • Table 6: Canadian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Multinational Companies Leverage Japan's Relaxed Regulatory Regime for Furthering Stem Cell Research
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 7: Japanese Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 8: European Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - France, Germany, Italy, UK, Spain, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 9: European 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of European Markets for Years 2017 & 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 10: French Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

4b. GERMANY

  • Market Analysis
    • Table 11: German Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 12: Italian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Stem Cell Storage Venture by NHS Trust Aims to Improve Public Donation
    • UK Scientists Use Adult-Stem Cells for Treating Multiple Sclerosis
  • B. Market Analytics
    • Table 13: The UK Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 14: Spanish Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Stem Cell Research Gains Momentum in Russia
  • B. Market Analytics
    • Table 15: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • India & China: Potential-Laden Populous Markets for Stem Cell Research
    • Table 16: Ten Largest Populated Countries Worldwide (July 2015): Total Population (in Millions) by Age Group 0-14 Years, 15-59 Years, 60+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Mexico (includes corresponding Graph/Chart)
    • Product Launches
    • Strategic Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 17: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 18: Asia-Pacific 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2017 & 2024 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Chinese Stem Cell Market Set to Register Robust Growth
    • Chinese Market for Stem Cell Research: Lack of Technological Innovation Restrains Governmental Initiatives
  • B. Market Analytics
    • Table 19: Chinese Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Steady Strides in India's Stem Cells Market
    • Regulatory Guidelines Promote Ethical Harvesting of Stem Cells
    • Indian Researchers use Hair Follicle and Skin Stem Cells for Burn and Vitiligo Patients
    • Stem Cell Research-Imperative for Australia
    • Korean Scientists Develop Technique to Use Stem Cells for Treating Macular Degeneration
      • Select Stem Cell Products Approved in the Korean Market
  • B. Market Analytics
    • Table 20: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 21: Latin American Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - Brazil, and Rest of Latin America Markets Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 22: Latin American 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil, and Rest of Latin America Markets for Years 2017 & 2024 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 23: Brazilian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 24: Rest of Latin America Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Select Key Player
  • B. Market Analytics
    • Table 25: Rest of World Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top